GPR22
gene geneOn this page
Summary
GPR22 (G protein-coupled receptor 22, HGNC:4477) is a protein-coding gene on chromosome 7q22.3, encoding G-protein coupled receptor 22 (Q99680). Orphan G-protein coupled receptor.
This gene is a member of the G-protein coupled receptor 1 family and encodes a multi-pass membrane protein.
Source: NCBI Gene 2845 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 3 total
- Druggable target: yes
- MANE Select transcript:
NM_005295
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4477 |
| Approved symbol | GPR22 |
| Name | G protein-coupled receptor 22 |
| Location | 7q22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000172209 |
| Ensembl biotype | protein_coding |
| OMIM | 601910 |
| Entrez | 2845 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000304402, ENST00000473300, ENST00000496754, ENST00000890166, ENST00000960458, ENST00000960459
RefSeq mRNA: 1 — MANE Select: NM_005295
NM_005295
CCDS: CCDS5744
Canonical transcript exons
ENST00000304402 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001174047 | 107474035 | 107475684 |
| ENSE00001413461 | 107471372 | 107472302 |
| ENSE00001414143 | 107470057 | 107470445 |
Expression profiles
Bgee: expression breadth ubiquitous, 113 present calls, max score 95.24.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.8244 / max 172.2434, expressed in 130 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 80443 | 1.5695 | 124 |
| 80444 | 0.1965 | 75 |
| 204643 | 0.0584 | 34 |
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 95.24 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 89.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 86.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.46 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 84.70 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.60 | gold quality |
| frontal cortex | UBERON:0001870 | 84.36 | gold quality |
| cerebral cortex | UBERON:0000956 | 83.44 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.91 | gold quality |
| primary visual cortex | UBERON:0002436 | 81.70 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.05 | gold quality |
| heart left ventricle | UBERON:0002084 | 80.23 | gold quality |
| Ammon’s horn | UBERON:0001954 | 79.51 | gold quality |
| cardiac atrium | UBERON:0002081 | 79.13 | gold quality |
| right atrium auricular region | UBERON:0006631 | 79.13 | gold quality |
| corpus callosum | UBERON:0002336 | 76.97 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.65 | gold quality |
| cerebellum | UBERON:0002037 | 76.52 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.43 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 76.09 | gold quality |
| heart | UBERON:0000948 | 75.88 | gold quality |
| amygdala | UBERON:0001876 | 75.18 | gold quality |
| temporal lobe | UBERON:0001871 | 75.17 | gold quality |
| brain | UBERON:0000955 | 73.11 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.76 | gold quality |
| apex of heart | UBERON:0002098 | 72.56 | gold quality |
| caudate nucleus | UBERON:0001873 | 67.74 | gold quality |
| bone marrow cell | CL:0002092 | 67.42 | silver quality |
| calcaneal tendon | UBERON:0003701 | 66.99 | gold quality |
| ventricular zone | UBERON:0003053 | 66.41 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6075 | no | 460.83 |
| E-ANND-3 | no | 1.20 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
81 targeting GPR22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
Literature-anchored findings (GeneRIF, showing 2)
- Demonstrate GRR22 expression in human heart. (PMID:18539757)
- Cardiomyocyte-specific overexpression of GPR22 ameliorates cardiac injury in mice with acute myocardial infarction. (PMID:38816768)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gpr22a | ENSDARG00000004592 |
| danio_rerio | gpr22b | ENSDARG00000045383 |
| mus_musculus | Gpr22 | ENSMUSG00000044067 |
| rattus_norvegicus | Gpr22 | ENSRNOG00000008423 |
| drosophila_melanogaster | CrzR | FBGN0036278 |
| caenorhabditis_elegans | WBGENE00013642 |
Paralogs (16): NPFFR2 (ENSG00000056291), GNRHR (ENSG00000109163), CCKBR (ENSG00000110148), HCRTR1 (ENSG00000121764), AVPR2 (ENSG00000126895), GALR3 (ENSG00000128310), HCRTR2 (ENSG00000137252), NPFFR1 (ENSG00000148734), CCKAR (ENSG00000163394), AVPR1A (ENSG00000166148), GALR1 (ENSG00000166573), GPR150 (ENSG00000178015), OXTR (ENSG00000180914), FFAR4 (ENSG00000186188), QRFPR (ENSG00000186867), AVPR1B (ENSG00000198049)
Protein
Protein identifiers
G-protein coupled receptor 22 — Q99680 (reviewed: Q99680)
All UniProt accessions (1): Q99680
UniProt curated annotations — full annotation on UniProt →
Function. Orphan G-protein coupled receptor. Seems to act through a G(i)/G(o) mediated pathway. May be involved in ciliogenesis.
Subcellular location. Cell membrane.
Tissue specificity. High expression in adult and fetal heart tissue. Expressed in the brain, with enrichment in the accumbens, amygdala, cerebellum, cortex, and hippocampus regions.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_005286* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF00001
UniProt features (19 total): topological domain 8, transmembrane region 7, glycosylation site 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99680-F1 | 72.19 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 16, 192
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 108 (showing top):
WWTAAGGC_UNKNOWN, LHX3_01, EFC_Q6, EVI1_05, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, WTGAAAT_UNKNOWN, TGACATY_UNKNOWN, GOBP_RESPONSE_TO_HORMONE, AACTTT_UNKNOWN, GOBP_CELL_PROJECTION_ORGANIZATION, MYB_Q5_01, TGGAAA_NFAT_Q4_01, TAATTA_CHX10_01, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED
GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), cell projection organization (GO:0030030), cellular response to hormone stimulus (GO:0032870), signal transduction (GO:0007165)
GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| cellular component organization | 1 |
| response to hormone | 1 |
| cellular response to chemical stimulus | 1 |
| cellular response to endogenous stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
754 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR22 | GPR20 | Q99678 | 974 |
| GPR22 | LPAR4 | Q99677 | 864 |
| GPR22 | CMKLR2 | P46091 | 816 |
| GPR22 | DUS4L | O95620 | 733 |
| GPR22 | COG5 | Q9UP83 | 699 |
| GPR22 | BCAP29 | Q9UHQ4 | 644 |
| GPR22 | SST | P01166 | 520 |
| GPR22 | PRKAR2B | P31323 | 503 |
| GPR22 | GPR142 | Q7Z601 | 503 |
| GPR22 | CCDC174 | Q6PII3 | 487 |
| GPR22 | GPR63 | Q9BZJ6 | 483 |
| GPR22 | GPR176 | Q14439 | 483 |
| GPR22 | GPR19 | Q15760 | 467 |
| GPR22 | GPR162 | Q16538 | 456 |
| GPR22 | MCF2L | O15068 | 443 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPR22 | CEBPE | psi-mi:“MI:0915”(physical association) | 0.370 |
| NFATC4 | GPR22 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GPR22 | TFAP2C | psi-mi:“MI:0915”(physical association) | 0.370 |
| ARGLU1 | PIAS2 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (3): NFATC4 (Two-hybrid), TFAP2C (Two-hybrid), GPR22 (Two-hybrid)
ESM2 similar proteins: A0A2R9YJI3, B2ZHY2, B3DM66, B4XF06, D4A3U0, O02777, O43194, O46635, P08909, P08911, P0C0W8, P14842, P18599, P20272, P21554, P28223, P28335, P32240, P34311, P34968, P35363, P47746, P50128, P50129, P56971, P70259, Q09502, Q333S9, Q5IS53, Q5IS66, Q5IS73, Q5IS98, Q5R4Q6, Q5U431, Q60F97, Q6DWJ6, Q71SP5, Q75Z89, Q801M1, Q80UC8
Diamond homologs: A0A2R9YJI3, D4A3U0, Q8BZL4, Q99680
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
344 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:107471370:A:G | acceptor_gain | 1.0000 |
| 7:107470443:GAG:G | donor_gain | 0.9900 |
| 7:107471367:ACAAG:A | acceptor_gain | 0.9900 |
| 7:107471369:A:AG | acceptor_gain | 0.9900 |
| 7:107471369:AAG:A | acceptor_gain | 0.9900 |
| 7:107471369:AAGG:A | acceptor_gain | 0.9900 |
| 7:107471511:GGAA:G | donor_gain | 0.9900 |
| 7:107474033:A:AG | acceptor_gain | 0.9900 |
| 7:107474034:G:GG | acceptor_gain | 0.9900 |
| 7:107470442:AGAGG:A | donor_loss | 0.9800 |
| 7:107470444:AGG:A | donor_loss | 0.9800 |
| 7:107470446:G:GC | donor_loss | 0.9800 |
| 7:107470447:T:A | donor_loss | 0.9800 |
| 7:107474029:TTCTA:T | acceptor_loss | 0.9800 |
| 7:107474030:TCTA:T | acceptor_loss | 0.9800 |
| 7:107474031:CTA:C | acceptor_loss | 0.9800 |
| 7:107474032:TAGGG:T | acceptor_loss | 0.9800 |
| 7:107474033:A:C | acceptor_loss | 0.9800 |
| 7:107471367:A:AG | acceptor_gain | 0.9700 |
| 7:107471368:C:G | acceptor_gain | 0.9700 |
| 7:107474033:AG:A | acceptor_gain | 0.9700 |
| 7:107474034:GG:G | acceptor_gain | 0.9700 |
| 7:107474080:T:TA | acceptor_gain | 0.9700 |
| 7:107470446:G:GG | donor_gain | 0.9600 |
| 7:107472059:T:G | acceptor_gain | 0.9600 |
| 7:107474034:GGGA:G | acceptor_gain | 0.9500 |
| 7:107471498:GAGT:G | donor_gain | 0.9400 |
| 7:107471755:G:GT | donor_gain | 0.9400 |
| 7:107474575:T:A | donor_gain | 0.9400 |
| 7:107471370:AG:A | acceptor_gain | 0.9300 |
AlphaMissense
2845 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:107474223:G:A | G55R | 0.999 |
| 7:107474223:G:C | G55R | 0.999 |
| 7:107474224:G:A | G55E | 0.999 |
| 7:107474232:A:C | S58R | 0.999 |
| 7:107474234:C:A | S58R | 0.999 |
| 7:107474234:C:G | S58R | 0.999 |
| 7:107474311:T:C | L84P | 0.999 |
| 7:107474323:A:C | D88A | 0.999 |
| 7:107474323:A:T | D88V | 0.999 |
| 7:107475024:T:C | F322L | 0.999 |
| 7:107475026:T:A | F322L | 0.999 |
| 7:107475026:T:G | F322L | 0.999 |
| 7:107475036:T:A | W326R | 0.999 |
| 7:107475036:T:C | W326R | 0.999 |
| 7:107475043:C:G | P328R | 0.999 |
| 7:107475151:C:A | P364H | 0.999 |
| 7:107475151:C:G | P364R | 0.999 |
| 7:107474237:C:A | N59K | 0.998 |
| 7:107474237:C:G | N59K | 0.998 |
| 7:107474289:A:C | S77R | 0.998 |
| 7:107474291:T:A | S77R | 0.998 |
| 7:107474291:T:G | S77R | 0.998 |
| 7:107474334:T:C | C92R | 0.998 |
| 7:107474436:A:C | S126R | 0.998 |
| 7:107474438:T:A | S126R | 0.998 |
| 7:107474438:T:G | S126R | 0.998 |
| 7:107474479:G:C | R140T | 0.998 |
| 7:107474480:A:C | R140S | 0.998 |
| 7:107474480:A:T | R140S | 0.998 |
| 7:107474481:T:G | Y141D | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000598964 (7:107469638 A>G), RS1000699137 (7:107477228 A>G), RS1000723431 (7:107476857 T>C,G), RS1000928679 (7:107469839 T>A), RS1001663807 (7:107470157 C>A,G), RS1001814651 (7:107476822 T>A), RS1002430620 (7:107469215 T>C), RS1002872265 (7:107468951 G>A), RS1004165862 (7:107471972 T>A,C), RS1004631495 (7:107478191 T>C), RS1004808754 (7:107473571 C>G), RS1004882596 (7:107471840 A>G), RS1005182852 (7:107473934 A>C), RS1005467435 (7:107470211 A>G), RS1006169838 (7:107478242 A>G)
Disease associations
OMIM: gene MIM:601910 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005956_26 | Waist-to-hip ratio adjusted for BMI | 2.000000e-08 |
| GCST005962_48 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 2.000000e-06 |
| GCST90013406_282 | Liver enzyme levels (alkaline phosphatase) | 1.000000e-25 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0004533 | alkaline phosphatase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523914 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with no pharmacology
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Doxorubicin | decreases expression | 2 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| entinostat | decreases expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Thimerosal | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883440 | Binding | PRESTO-Tango GPCRome screening (GPR22) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_LA42 | PathHunter U2OS GPR22 beta-arrestin | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.